Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Gains 5%; BSE HEALTHCARE Index Up 0.8%
Thu, 8 Aug 11:33

KRSNAA DIAGNOSTICS Gains 5%; BSE HEALTHCARE Index Up 0.8%Image source: Kameleon007 /www.istockphoto.com

KRSNAA DIAGNOSTICS share price has zoomed 5% and is presently trading at Rs 706.5.

Meanwhile, the BSE HEALTHCARE index is at 41,161.2 (up 0.8%).

Among the top gainers in the BSE HEALTHCARE index today are Abbott India (up 3.6%) and ALEMBIC PHARMA (up 3.4%).

DR. LAL PATHLABS (down 2.0%) and FDC (down 1.5%) are among the top losers today.

Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 523.0 to Rs 706.5, registering a gain of Rs 183.5 (up 35.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,300.0 to 41,161.2, registering a gain of 45.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 116.8%), GSK Pharma (up 108.2%) and SUVEN PHARMACEUTICALS (up 105.9%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,161.9 (down 0.4%).

The top losers among the BSE Sensex today are Infosys (down 2.2%) and Asian Paints (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,197.2 (down 0.4%). BPCL and Infosys are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,953.5 to 79,161.9, registering a gain of 13,208.4 points (up 20.0%).

KRSNAA DIAGNOSTICS Financial Update...

KRSNAA DIAGNOSTICS net profit grew 22.4% YoY to Rs 179 million for the quarter ended June 2024, compared to a profit of Rs 146 million a year ago. Net sales rose 22.0% to Rs 1,702 million during the period as against Rs 1,396 million in April-June 2023.

For the year ended March 2023, KRSNAA DIAGNOSTICS reported 9.2% decrease in net profit to Rs 621 million compared to net profit of Rs 684 million during FY22. Revenue of the company grew 7.0% to Rs 4,871 million during FY23.

The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 37.9.


Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 5%; BSE HEALTHCARE Index Up 0.8%". Click here!